{"id":"W1544742800","doi":"10.1002/cncr.21695","title":"First‐ and second‐line chemotherapy with docetaxel or mitoxantrone in patients with hormone‐refractory prostate cancer","year":2006,"lang":"en","type":"article","venue":"Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Abbott Laboratories","keywords":"Mitoxantrone; Medicine; Docetaxel; Oncology; Chemotherapy; Prostate cancer; Internal medicine; Cancer; Refractory (planetary science); Prostate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006186367,0.0002270884,0.0006703604,0.0002748349,0.0002612169,0.0004633845,0.0002134416,0.0004512199,0.0005813999],"category_scores_gemma":[0.002074207,0.0001855839,0.0004942206,0.0003415266,0.0003145645,0.0002667387,0.0001752611,0.0004820419,0.0001002803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000411713,"about_ca_system_score_gemma":0.0005800005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007897226,"about_ca_topic_score_gemma":0.001652076,"domain_scores_codex":[0.9996692,0.0001381886,0.000028435,0.00005078178,0.00005989329,0.00005347093],"domain_scores_gemma":[0.9990299,0.0003555128,0.0003141112,0.00003583415,0.00003682115,0.0002278645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01531647,0.001043395,0.9169797,0.0002218359,0.0005114652,0.0007902257,0.0002712775,0.001023964,0.004004445,0.0000500829,0.0005271247,0.05926008],"study_design_scores_gemma":[0.002882262,0.03925285,0.9456284,0.00006614796,0.0005731892,0.005351209,0.0002458717,0.001983761,0.001940765,0.0001228583,0.001921201,0.00003154676],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969663,0.002605785,0.00008416275,0.00006093373,0.000009277024,0.00002097761,0.00003428487,0.000005410812,0.0002128166],"genre_scores_gemma":[0.9989888,0.0006653813,0.00009908231,0.00006711371,0.00002874232,0.0000184375,0.00008351432,0.000001268993,0.00004778494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007897226,"threshold_uncertainty_score":0.003271699,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009183391678185947,"score_gpt":0.2689616571266287,"score_spread":0.2597782654484427,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}